BioSpace News Archive

Alteogen Inc. (KOSDAQ:196170), a Korean biotech company announced that their recently concluded clinical trial of Tergase® showed zero incidence of ADA (including neutralizing antibodies). Tergase® is Alteogen’s first proprietary product currently under pharmaceutical approval process by the Korean Ministry of Food and Drug Safety.

Cardiff Oncology, Inc. today announced that company management will present at the Baird Global Healthcare Conference on September 12, 2023.

Kintara Therapeutics, Inc. today announced that it will be presenting a poster at the 2023 European Association for Neuro-Oncology (EANO) Annual Meeting, taking place in Rotterdam, September 21-24, 2023.

InMode Ltd., a leading global provider of innovative medical technologies, announced the participation at the following investor conferences and events in September.

Find Therapeutics Inc., a biopharmaceutical company focused on the development of innovative therapies for autoimmune diseases, announced the appointment of Robert L. Glanzman, M.D. FAAN, as Chief Medical Officer.

Intensity Therapeutics, Inc. (Nasdaq: INTS) today announced that Lewis H. Bender, President and Chief Executive Officer, will present a company overview at the H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, at 4:30 pm ET.

GSK plc and YMCA of the USA will host GSK’s Sideline RSV “Community Conversations” event series as part of their campaign efforts to raise awareness about RSV infection in older adults.

Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and services, announces that management will participate in the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023

CG Oncology, Inc. announced the appointment of three new members to its executive leadership team: Ambaw Bellete as President and Chief Operating Officer, Swapnil Bhargava, Ph.D. as Chief Technical Officer, and Vijay Kasturi, M.D. as Chief Medical Officer.

Forge Biologics, a leading manufacturer of genetic medicines, announced today that company leadership will be delivering presentations, participating in fireside chats, and taking one-on-one meetings at four September investor conferences.